Brain Cancer Clinical Trials in Cleveland

Showing 81-100 of 100 trials

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

NCT00540722

This phase II trial is studying how well gossypol works in treating patients with progressive or recurrent glioblastoma multiforme. Gossypol may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more

National Cancer Institute (NCI)56 participantsStarted Jan 2008

Birmingham, Alabama, United States • Tampa, Florida, United States • Baltimore, Maryland, United States +5 more locations

TERMINATEDPHASE2< 1 mile

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma

NCT01122901

This phase II trial is studying how well gamma-secretase/Notch signalling pathway inhibitor RO4929097 works in treating patients with recurrent or progressive glioblastoma. Gamma-secretase/Notch signalling pathway inhibitor RO4929097 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more

National Cancer Institute (NCI)47 participantsStarted Dec 2010

Atlanta, Georgia, United States • Detroit, Michigan, United States • Cleveland, Ohio, United States +2 more locations

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma

Brain Cancer Trials in Other Cities

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma

Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors

Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors

Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma

A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas

A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma

AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors

Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma

Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)

A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma

A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma

A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma

Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients

A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma

Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Other Conditions in Cleveland